Title: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Publisher: NEJM
Publication Date: 07 May 2020
URL: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2006923
Key Takeaways: As you saw in last week’s Intelligence Report, there has been a debate over the association of ACE inhibitors and increased risk of developing COVID or having a more severe disease course. This large observational study does not support this theory and supports the safety of using ACE inhibitors in COVID patients.
The Himmelfarb Health Sciences Library
Questions? Ask us.
